Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 78.40
-0.90 (-1.13%)
At close: Oct 9, 2025
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 4.02 billion as of October 10, 2025. Its market cap has increased by 162.72% in one year.
Market Cap
4.02B
Enterprise Value
3.63B
Revenue
159.02M
Ranking
n/a
PE Ratio
191.76
Stock Price
78.40
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 4.02B, an increase of 189.11%. That is a compound annual growth rate of 141.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 4.02B | 143.11% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Semiconductor Manufacturing Company | 37.34T |
| Hon Hai Precision Industry | 3,076.68B |
| Delta Electronics | 2,594.95B |
| MediaTek | 2,143.75B |
| Fubon Financial Holding | 1,257.86B |
| Quanta Computer | 1,148.65B |
| Chunghwa Telecom | 1,031.74B |
| Cathay Financial Holding | 974.04B |